Epilepsy
📧 Sign up to get email alerts when something new happens for Epilepsy.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2009-01-15FDA Approved: LEVETIRACETAM — Original Application (Lupin Pharmaceuticals, Inc.)
FDA approved Lupin Pharmaceuticals' original application for a generic version of levetiracetam.
-
FDA approval · 2009-01-15FDA Approved: LEVETIRACETAM — Original Application (Exelan Pharmaceuticals, Inc.)
FDA approved Exelan Pharmaceuticals' levetiracetam generic under Original Application (ANDA078234). This approval establishes a generic anti…
-
FDA approval · 2009-01-15FDA Approved: LEVETIRACETAM — Original Application (Patrin Pharma, Inc.)
FDA approved a generic version of levetiracetam under an original ANDA from Patrin Pharma, Inc. This marks the availability of a generic alt…
-
FDA approval · 2009-01-15FDA Approved: LEVETIRACETAM — Original Application (Torrent Pharmaceuticals Limited)
FDA approved Torrent Pharmaceuticals Limited's original application for levetiracetam, granting approval of a generic version of the antisei…
-
FDA approval · 2009-01-15FDA Approved: LEVETIRACETAM — Original Application (Dr. Reddy's Laboratories Limited)
FDA approved the original generic application for levetiracetam by Dr. Reddy's Laboratories Limited. The approval authorizes a generic versi…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2009-01-15FDA Approved: LEVETIRACETAM — Original Application (Dr. Reddy's Laboratories Limited)
FDA approved Dr. Reddy's Laboratories Limited's generic levetiracetam (Original Application), making a generic antiepileptic product availab…
-
FDA approval · 2009-01-15FDA Approved: LEVETIRACETAM — Original Application (Aurobindo Pharma Limited)
The FDA approved a generic levetiracetam product from Aurobindo Pharma Limited under an Original Application (ANDA 079063). This clearance a…
-
FDA approval · 2008-11-25FDA Approved: DIVALPROEX SODIUM — Original Application (Bionpharma Inc.)
FDA approved Bionpharma's original application for divalproex sodium, making a generic version available for epilepsy, bipolar disorder, and…
-
FDA approval · 2008-11-12FDA Approved: EXTENDED PHENYTOIN SODIUM — Original Application (Amneal Pharmaceuticals LLC)
FDA approved Amneal Pharmaceuticals LLC's extended-release phenytoin sodium as a generic drug via an Original Application (ANDA). This appro…
-
FDA approval · 2008-11-04FDA Approved: LEVETIRACETAM — Original Application (Mylan Pharmaceuticals Inc.)
FDA approved the original application for a generic version of levetiracetam by Mylan Pharmaceuticals Inc.
-
FDA approval · 2008-10-28FDA Approved: VIMPAT — Original Application (UCB, Inc.)
FDA approved VIMPAT (lacosamide) under Original Application by UCB, Inc., marking the initial approval for the treatment of partial-onset se…
-
FDA approval · 2008-10-28FDA Approved: VIMPAT — Original Application (UCB, Inc.)
FDA approved VIMPAT (lacosamide) through its original NDA for adjunctive treatment of partial-onset seizures in adults and in pediatric pati…
-
FDA approval · 2008-09-12FDA Approved: KEPPRA XR — Original Application (UCB, Inc.)
The FDA approved KEPPRA XR (levetiracetam) under an original NDA from UCB, Inc., introducing an extended-release formulation of Keppra for e…
-
FDA approval · 2008-09-10FDA Approved: LORAZEPAM — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved a supplemental application for lorazepam submitted by Teva Pharmaceuticals USA, Inc., under the existing approval of the dr…
-
FDA approval · 2008-07-29FDA Approved: DIVALPROEX SODIUM — Original Application (Lupin Pharmaceuticals, Inc.)
FDA approved Lupin Pharmaceuticals' generic divalproex sodium (Original Application), enabling a generic version of the reference product.
-
FDA approval · 2008-07-29FDA Approved: DIVALPROEX SODIUM — Original Application (Sun Pharmaceutical Industries, Inc.)
FDA approved Sun Pharmaceutical Industries' divalproex sodium as an original ANDA (generic) application.
-
FDA approval · 2008-07-29FDA Approved: DIVALPROEX SODIUM — Original Application (Dr.Reddy's Laboratories Limited)
FDA approved a generic version of divalproex sodium from Dr. Reddy's Laboratories Limited under an Original Application (ANDA).
-
FDA approval · 2008-07-28FDA Approved: CARBAMAZEPINE — Supplemental Application (Apotex Corp.)
FDA approved Apotex Corp.'s supplemental application for carbamazepine (generic), signifying approval of a supplemental ANDA for this produc…
-
FDA approval · 2008-07-23FDA Approved: DIAZEPAM — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved a supplemental application for diazepam filed by Teva Pharmaceuticals USA, Inc., updating/expanding its labeling.
-
FDA approval · 2008-06-30FDA Approved: PHENYTOIN SODIUM — Original Application (Sun Pharmaceutical Industries, Inc.)
FDA approves Sun Pharmaceutical's Phenytoin Sodium as an oral generic anticonvulsant indicated for the control of seizures in epilepsy.
-
FDA approval · 2008-06-13FDA Approved: MYSOLINE — Supplemental Application (Bausch Health US, LLC)
FDA approves a supplemental application for Mysoline (primidone) submitted by Bausch Health US, LLC. The action approves changes to the prod…
-
FDA approval · 2008-04-23FDA Approved: PRIMIDONE — Original Application (Amneal Pharmaceuticals LLC)
The FDA approved Amneal Pharmaceuticals' original ANDA for Primidone, enabling the marketing of a generic Primidone product.
-
FDA approval · 2008-04-21FDA Approved: CARBAMAZEPINE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a supplemental application for carbamazepine from Sun Pharmaceutical Industries, Inc., updating the approved generic product un…
-
FDA approval · 2008-04-17FDA Approved: CARBAMAZEPINE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
The FDA approved a supplemental application for carbamazepine submitted by Sun Pharmaceutical Industries, Inc.
-
FDA approval · 2008-04-09FDA Approved: OXCARBAZEPINE — Original Application (Advagen Pharma Limited)
The FDA approved Advagen Pharma Limited's original ANDA for oxcarbazepine, a generic anticonvulsant.